跳至主要内容
临床试验/NCT01665378
NCT01665378已完成不适用

Impact of Pre-Pregnancy Micronutrient Supplementation on Maternal and Child Outcomes

Emory University2 个研究点 分布在 1 个国家目标入组 5,011 人开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,011
试验地点
2
主要终点
Birth Size

研究概览

简要总结

The study evaluates the efficacy of providing weekly iron-folate (IFA) supplements or Multiple Micronutrient (MM) supplements before pregnancy in increasing birth weight and duration of gestation as well as maternal and infant iron status.

详细描述

Low birth weight and anemia remain intractable problems in many developing countries despite considerable efforts to address them. Intervening with just prenatal iron-folate (IFA) supplements may not be the best approach given the substantial demands for iron by maternal and fetal tissues. Therefore, there is an urgent need to evaluate the additional contribution of prepregnancy interventions.

The study evaluates the efficacy of providing weekly iron-folate (IFA) supplements or Multiple Micronutrient (MM) supplements before pregnancy in increasing birth weight and duration of gestation as well as maternal and infant iron status.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-35 years old
  • Currently married
  • Currently living in one of the 10 communes and intends to live in the areas for 24 months following recruitment
  • Plans to have children in the next year
  • Agrees to participate with informed consent

排除标准

  • Currently pregnant
  • Delivered in the previous six months
  • Regularly consumed IFA or MM supplements in the past 2 months
  • Severe anemia (Hb < 7 g/L)
  • History of high risk pregnancy including abruptio placenta, placenta previa, gestational diabetes, pregnancy induced hypertension, coagulation disorders, thrombocytopenia or chronic vascular, renal or systemic disease and drug use
  • Chronic hematological diseases, hereditary defects of red cells or hemoglobin

结局指标

主要结局

Birth Size

时间窗: At birth

Infants' weight, length and head circumference will be measured as early as possible within 24 hours after birth using standard procedures. All measurements will be obtained in duplicate by the same data collector. Weight-for-age and length-for-age z scores will be calculated using the 2006 WHO reference data.

Gestational Age

时间窗: At birth

Gestational age will be calculated based on the date of last menstrual period. This method has been shown to be reliable in previous work and we expect precise estimates since we will be visiting women weekly from baseline during the prepregnancy period and will exclude women who may be have delivered in the past 6 months.

Child growth

时间窗: From birth through 24 months

Length and weight will be measured at birth, 1, 3, 6, 9, 12, 15, 18, and 24 mo

Child development

时间窗: Up to 7 years post enrollment

Child development will be measured using the Bayley Scales for Infant Development III at 12 and 24 mo and the Wechsler Intelligence Scale for Children at age 6-7 y

Weight-for-age Z score (WAZ)

时间窗: Up to 7 years post enrollment

Weight-for-age Z score (WAZ) in offspring of women receiving only FA, offspring of women who receive weekly pre-pregnancy IFA, and offspring of women who receive weekly MM supplements

Body composition (Lean mass/fat free mass index)

时间窗: Up to 7 years post enrollment

Body composition (Lean mass/fat free mass index) in offspring of women receiving only FA, offspring of women who receive weekly pre-pregnancy IFA, and offspring of women who receive weekly MM supplements

Height-for-age Z score (HAZ)

时间窗: Up to 7 years post enrollment

Height-for-age Z score (HAZ) in offspring of women receiving only FA, offspring of women who receive weekly pre-pregnancy IFA, and offspring of women who receive weekly MM supplements

Weight -for-Height Z (WHZ) or Body Mass Index Z score (BMIZ)

时间窗: Up to 7 years post enrollment

Weight -for-Height Z score (WHZ) or BMIZ in offspring of women receiving only FA, offspring of women who receive weekly pre-pregnancy IFA, and offspring of women who receive weekly MM supplements

次要结局

  • Maternal depression(At baseline, during pregnancy, 3 months postpartum)
  • Mothers' iron status(At baseline and 1 and 3 months post partum)
  • Infants' iron status(1 and 3 months of age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Usha Ramakrishnan

Professor

Emory University

研究点 (2)

Loading locations...

相似试验